Search

Search Constraints

You searched for: Author/Creator Iannone, F.

Search Results

13. AB0380 The Inhibition of Tumor Necrosis Factor-Alpha (TNFA) Reduce Plasmatic Reactive Oxygen Metabolites (ROM) of Rheumatoid Arthritis (RA) Patients. (10th June 2014)

14. AB0381 Long-Term Clinical Effectiveness of Adalimumab, Etanercept, and Infliximab in Rheumatoid Arthritis (RA): an Observational Study from Italian Register, Gisea. (10th June 2014)

15. AB0397 GO.A.RE.L. (Golimumab in Apulian Real-Life Patients) Study. Preliminary Data from Golimumab Therapy in Patients Affected with Polyarthritis. A Multicentre Experience in Apulia (Southern Italy). (10th June 2014)

16. AB0416 Early Good Eular Response Predicts Low/Remission Disease State in Rheumatoid Arthritis Patients on Treatment with Certolizumab in Real Life Settings. Data from Italian Registry Gisea. (9th June 2015)

17. AB0420 Drug survival on certolizumab and predictors thereof in patients with rheumatoid arthritis, psoriatic arthritis, and axial-spondyloarthritis from the apulian biopure registry. (12th June 2018)

18. AB0440 The Impact of Patient Characteristics and Past Treatment History on the Evolution of Functional Disability in RA Patients Treated with Abatacept. A Pan-European Analysis of RA Registries. (9th June 2015)

20. AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients. (9th June 2015)